Zanepezil

Zanepezil Uses, Dosage, Side Effects, Food Interaction and all others data.

Zanepezil (TAK-147) is a selective acetylcholine (ACh) esterase inhibitor under investigation as a drug for Alzheimer's disease (AD) treatment.

Zanepezil is an acetylcholinesterase inhibitor being developed by Takeda for the treatment of dementia in subjects with Alzheimer’s disease. In May 2003, the company discontinued development of the compound due to a lack of a dose-dependent effect in the trials.

Table Of contents

• Zanepezil
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Zanepezil
Generic	Zanapezil
Zanapezil Other Names	Zanapezil, Zanepezil
Type
Formula	C25H32N2O
Weight	Average: 376.5344 Monoisotopic: 376.251463656
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

For the treatment of dementia in subjects with Alzheimer’s disease.

How Zanepezil works

Zanepezil inhibits the degradation of acetylcholine, a neurotransmitter, to prevent the reduction of cerebral acetylcholine levels and to enhance the mental function of patients with dementia. It is expected to act selectively on the central nervous system, resulting in fewer peripheral adverse reactions.

Innovators Monograph

You find simplified version here Zanepezil